Independent website, not affiliated with any government.

Wikipedia: Current events United States · Event

Event

FDA orders GLP-1 drug warnings over blindness risk

Summary by AI of Wikipedia's text

The US FDA ordered GLP-1 medicine manufacturers to add warnings about a risk of permanent blindness.

The United States Food and Drug Administration has ordered manufacturers of GLP-1 medicines, including semaglutide and tirzepatide, to include warnings about potential eye risks. These drugs, used for type 2 diabetes and weight loss, may increase the risk of non-arteritic anterior ischemic optic neuropathy, a disorder that can cause permanent blindness.
The FDA is a federal agency within the United States Department of Health and Human Services responsible for supervising pharmaceutical drugs and public health.

Headlines and summaries are written by AI for Outer News (RS Elite Pro s.r.o.) from Wikipedia's text and are not reviewed by a person. They can contain mistakes: before you rely on one, read the original.

Read on Wikipedia en.wikipedia.org

Source: Wikipedia: Current events · CC BY-SA 4.0

Get the app

Official decisions from around the world, in a few calm sentences, on your phone.